Percutaneous left atrial appendage closure (LAAC) is not inferior to direct oral anticoagulants (DOACs) in the prevention of major atrial fibrillation (AF)-related cardiovascular, neurological, and bleeding events, results of a recent study have shown.
Practicing Tai Chi proved effective in enhancing the psychological well-being of older adults (≥60 years) with cardiovascular disease (CVD), consequently improving their quality of life (QoL), a meta-analysis has shown.
Catheter ablation reduces recurrence of any atrial fibrillation (AF) by 48 percent and symptomatic AF by 51 percent compared with drug therapy over 5 years of follow-up, reports a study. Catheter ablation patients also have significantly lower AF burden regardless of baseline AF type.
Cardiovascular (CV) risk prediction algorithms tend to be inaccurate, frequently underestimating and sometimes overestimating the risk of CV in patients with inflammatory rheumatic diseases, a recent study has shown.
A novel, sirolimus-eluting bioresorbable scaffold (BRS) has demonstrated potential in treating single coronary lesions, holding promise in vascular restoration therapy, the RENASCENT II* trial has shown.
Proactive treatment with high-dose intravenous (IV) iron reduces the risk for type 1 or classic myocardial infarction (MI), but not type 2 MI, in patients with chronic kidney disease (CKD) on dialysis, according to a prespecified secondary analysis of the PIVOTAL study.
Targeting a low-density lipoprotein cholesterol level <70 mg/dL following an ischaemic stroke of atherosclerotic origin helps to avoid one in four subsequent major vascular events without increasing the risk of intracranial haemorrhage over about 5 years of follow-up, according to data from the Treat Stroke to Target trial.
Small dense low-density lipoprotein cholesterol (sd-LDL-C) is a strong predictor of stroke severity and intracranial artery calcification (IAC) in patients with acute ischaemic stroke (AIS), a study has shown.